The relationship between liver peroxisome proliferation and adipose tissue atrophy induced by peroxisome proliferator exposure and withdrawal in mice

Biochemical Pharmacology

Volumn 66, Issue 5, 2003, Pages 749-756

  Xie, Yi ^a   Yang, Qian ^a   Nelson, B Dean ^a   DePierre, Joseph W ^a  

^a STOCKHOLM UNIVERSITY   (Sweden)

Author keywords

Adipose tissue; Cholesterol; Hormone sensitive lipase; Lipoprotein lipase; Perfluorooctanoic acid; Peroxisome proliferator

Indexed keywords

CHOLESTEROL; LIPOPROTEIN LIPASE; PERFLUOROOCTANE; PEROXISOME PROLIFERATOR; TRIACYLGLYCEROL LIPASE;

ADIPOSE TISSUE; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CHOLESTEROL BLOOD LEVEL; CONTROLLED STUDY; DRUG EXPOSURE; DRUG WITHDRAWAL; ENZYME ACTIVITY; ENZYME ASSAY; HORMONE SENSITIVITY; LIPID PEROXIDATION; LIVER WEIGHT; MALE; MOUSE; MUSCLE ATROPHY; NONHUMAN; PRIORITY JOURNAL; WEIGHT GAIN; WEIGHT REDUCTION;

EID: 0041429151     PISSN: 00062952     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0006-2952(03)00386-1     Document Type: Article

References (33)

1. Corton J.C., Lapinskas P.J., Gonzalez F.J. Central role of PPARalpha in the mechanism of action of hepatocarcinogenic peroxisome proliferators. Mutat. Res. 448:2000;139-151.
2. Xie Y., Yang Q., Nelson B.D., DePierre J.W. Characterization of the adipose tissue atrophy induced by peroxisome proliferators in mice. Lipids. 37:2002;139-146.
3. Madsen L., Guerre-Millo M., Flindt E.N., Berge K., Tronstad K.J., Bergene E., Sebokova E., Rustan A.C., Jensen J., Mandrup S., Kristiansen K., Klimes I., Staels B., Berge R.K. Tetradecylthioacetic acid prevents high fat diet induced adiposity and insulin resistance. J. Lipid Res. 43:2002;742-750.
4. Guerre-Millo M., Gervois P., Raspe E., Madsen L., Poulain P., Derudas B., Herbert J.M., Winegar D.A., Willson T.M., Fruchart J.C., Berge R.K., Staels B. Peroxisome proliferator-activated receptor alpha activators improve insulin sensitivity and reduce adiposity. J. Biol. Chem. 275:2000;16638-16642.
5. Tsuboyama-Kasaoka N., Takahashi M., Tanemura K., Kim H.J., Tange T., Okuyama H., Kasai M., Ikemoto S., Ezaki O. Conjugated linoleic acid supplementation reduces adipose tissue by apoptosis and develops lipodystrophy in mice. Diabetes. 49:2000;1534-1542.
6. Mancini F.P., Lanni A., Sabatino L., Moreno M., Giannino A., Contaldo F., Colantuoni V., Goglia F. Fenofibrate prevents and reduces body weight gain and adiposity in diet-induced obese rats. FEBS Lett. 491:2001;154-158.
7. DePierre J.W., Sohlenius A.K., Cai Y., Eriksson A.M., Andersson K., Sundberg C. Peroxisome proliferation in response to xenobiotics. Biochem. Soc. Trans. 23:1995;425-429.
8. Staels B., Dallongeville J., Auwerx J., Schoonjans K., Leitersdorf E., Fruchart J.C. Mechanism of action of fibrates on lipid and lipoprotein metabolism. Circulation. 98:1998;2088-2093.
9. Malmendier C.L., Lontie J.F., Delcroix C., Dubois D.Y., Magot T., De Roy L. Apolipoproteins C-II and C-III metabolism in hypertriglyceridemic patients. Effect of a drastic triglyceride reduction by combined diet restriction and fenofibrate administration. Atherosclerosis. 77:1989;139-149.
10. Staels B., Vu-Dac N., Kosykh V.A., Saladin R., Fruchart J.C., Dallongeville J., Auwerx J. Fibrates downregulate apolipoprotein C-III expression independent of induction of peroxisomal acyl coenzyme A oxidase. A potential mechanism for the hypolipidemic action of fibrates. J. Clin. Invest. 95:1995;705-712.
11. Auwerx J., Schoonjans K., Fruchart J.C., Staels B. Transcriptional control of triglyceride metabolism: fibrates and fatty acids change the expression of the LPL and apo C-III genes by activating the nuclear receptor PPAR. Atherosclerosis. 124(Suppl.):1996;S29-S37.
12. Okochi E., Nishimaki-Mogami T., Suzuki K., Takahashi A. Perfluorooctanoic acid, a peroxisome-proliferating hypolipidemic agent, dissociates apolipoprotein B48 from lipoprotein particles and decreases secretion of very low density lipoproteins by cultured rat hepatocytes. Biochim. Biophys. Acta. 1437:1999;393-401.
13. Nishimaki-Mogami T., Suzuki K., Takahashi A. The role of phosphatidylethanolamine methylation in the secretion of very low density lipoproteins by cultured rat hepatocytes: rapid inhibition of phosphatidylethanolamine methylation by bezafibrate increases the density of apolipoprotein B48-containing lipoproteins. Biochim. Biophys. Acta. 1304:1996;21-31.
14. Sohlenius A.K., Lundgren B., DePierre J.W. Perfluorooctanoic acid has persistent effects on peroxisome proliferation and related parameters in mouse liver. J. Biochem. Toxicol. 7:1992;205-212.
15. Saha S.K., Moriya M., Ohinata H., Kuroshima A. Lipid interference with fluorometric assay of DNA in adipose tissues under various conditions. Jpn. J. Physiol. 44:1994;421-431.
16. Bieber L.L., Abraham T., Helmrath T. A rapid spectrophotometric assay for carnitine palmitoyltransferase. Anal. Biochem. 50:1972;509-518.
17. Del Prado M., Hernandez-Montes H., Villalpando S. Characterization of a fluorometric method for lipoprotein lipase. Arch. Med. Res. 25:1994;331-335.
18. Herrera E., Lasuncion M.A., Castro M., Gomez-Coronado D., Martin A., Quack G. Studies with etofibrate in the rat. Part I. Effects on glycerol, free fatty acid and triacylglycerol metabolism. Biochim. Biophys. Acta. 963:1988;42-52.
19. Brandes R., Arad R., Bar-Tana J. Adipose conversion of cultured rat primary preadipocytes by hypolipidemic drugs. Biochim. Biophys. Acta. 877:1986;314-321.
20. Converse CA, Skinner ER. Lipoprotein analysis: a practical approach. New York: Oxford University Press; 1992.
21. Nemeth P.M., Hitchins O.E., Solanki L., Cole T.G. Fluorometric procedures for measuring triglyceride concentrations in small amounts of tissue and plasma. J. Lipid Res. 27:1986;447-452.
22. Heider J.G., Boyett R.L. The picomole determination of free and total cholesterol in cells in culture. J. Lipid Res. 19:1978;514-518.
23. Lowry O.H., Rosebrough N.J., Farr A.L., Randall A.J. Protein measurement with the folin phenol reagent. J. Biol. Chem. 193:1951;265-275.
24. Berge R.K., Aarsland A. Correlation between the cellular level of long-chain acyl-CoA, peroxisomal beta-oxidation, and palmitoyl-CoA hydrolase activity in rat liver. Are the two enzyme systems regulated by a substrate-induced mechanism? Biochim. Biophys. Acta. 837:1985;141-151.
25. Stralfors P., Bjorgell P., Belfrage P. Hormonal regulation of hormone-sensitive lipase in intact adipocytes: identification of phosphorylated sites and effects on the phosphorylation by lipolytic hormones and insulin. Proc. Natl. Acad. Sci. U.S.A. 81:1984;3317-3321.
26. Zhang B., Berger J., Zhou G., Elbrecht A., Biswas S., White-Carrington S., Szalkowski D., Moller D.E. Insulin- and mitogen-activated protein kinase-mediated phosphorylation and activation of peroxisome proliferator-activated receptor gamma. J. Biol. Chem. 271:1996;31771-31774.
27. Gustavsson J., Parpal S., Karlsson M., Ramsing C., Thorn H., Borg M., Lindroth M., Peterson K.H., Magnusson K.E., Stralfors P. Localization of the insulin receptor in caveolae of adipocyte plasma membrane. FASEB J. 13:1999;1961-1971.
28. Parpal S., Karlsson M., Thorn H., Stralfors P. Cholesterol depletion disrupts caveolae and insulin receptor signaling for metabolic control via insulin receptor substrate-1, but not for mitogen-activated protein kinase control. J. Biol. Chem. 276:2001;9670-9678.
29. Schoonjans K., Staels B., Auwerx J. The peroxisome proliferator activated receptors (PPARS) and their effects on lipid metabolism and adipocyte differentiation. Biochim. Biophys. Acta. 1302:1996;93-109.
30. Fielding C.J. Caveolae and signaling. Curr. Opin. Lipidol. 12:2001;281-287.
31. Fielding C.J., Fielding P.E. Molecular physiology of reverse cholesterol transport. J. Lipid Res. 36:1995;211-228.
32. Yokoyama S. Apolipoprotein-mediated cellular cholesterol efflux. Biochim. Biophys. Acta. 1392:1998;1-15.
33. Hennuyer N., Poulain P., Madsen L., Berge R.K., Houdebine L.M., Branellec D., Fruchart J.C., Fievet C., Duverger N., Staels B. Beneficial effects of fibrates on apolipoprotein A-I metabolism occur independently of any peroxisome proliferative response. Circulation. 99:1999;2445-2451.